Editorial: Obesity, metabolic phenotypes and COVID-19

Metabolism. 2022 Mar:128:155121. doi: 10.1016/j.metabol.2021.155121. Epub 2022 Jan 10.

¹ 4th Department of Internal Medicine, Clinical Genomics and Pharmacogenomics Unit, 'Attikon' Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece; Center for New Biotechnologies and Precision Medicine, Medical School, National and Kapodistrian University of Athens, Athens, Greece; Molecular Biology Division, Biomedical Research Foundation of the Academy of Athens, Athens, Greece.
² Dalton Cardiovascular Research Center and Department of Medical Pharmacology and Physiology, School of Medicine, University of Missouri, Columbia, 65211, MO, USA. Electronic address: hillmi@missouri.edu.
³ Northeast Medical Group, Yale New Haven Health, New Haven, CT, USA.
⁴ Department of Medicine, Boston VA Healthcare System and Boston University School of Medicine, Boston, MA 02115, USA.
⁵ Department of Medicine, Boston VA Healthcare System and Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.

No abstract available

Keywords: COVID-19; NAFLD; Obesity; Obesity phenotypes; Outcomes; SARS-CoV-2; Treatment.

Publication types